Prime Highlights:

• UltraGreen has received regulatory approval for Verdye in the Philippines and IC-Flow Imaging System V2 in Malaysia, marking a major step in its Southeast Asia expansion.
• The approvals will help surgeons use advanced fluorescence-guided tools, improving surgical decisions and patient care.

Key Facts:

• Verdye (indocyanine green) is now available in the Philippines, providing a reliable imaging dye used worldwide in various surgical procedures.
• Malaysia’s approval of the IC-Flow Imaging System V2 enables hospitals to integrate fluorescence imaging technology into clinical practice.

Background:

Singapore-based UltraGreen Limited, a company specializing in fluorescence-guided surgery, has received approval for its Verdye dye in the Philippines and its IC-Flow Imaging System V2 in Malaysia. The company announced the milestone on Tuesday, marking an important step in its expansion across Southeast Asia, a region with rapidly growing healthcare demand.

Fluorescence-guided surgery, which uses indocyanine green (ICG), has become an essential tool across a variety of surgical procedures and specialties. The approval of Verdye in the Philippines provides clinicians access to a globally established ICG product, supported by extensive clinical experience in Europe, the United States, Asia, and other international markets. Malaysia’s approval of the IC-Flow Imaging System V2 allows hospitals to use fluorescence imaging technology in their surgeries.

Declan Cassells, Chief Operating Officer of UltraGreen, said the approvals are more than just formalities, they open the door for hospitals across Southeast Asia to use reliable surgical technology. He added that the approvals will help surgeons use advanced fluorescence-guided tools to make better decisions and improve patient care.

UltraGreen will work with local partners to offer training and promote the use of ICG techniques. The company provides quality imaging dyes and products to help surgeons make better decisions and provide consistent care across different surgeries.

Quek Mei Ling, Chief Business Officer (APAC), noted the region’s rising demand for surgical procedures in oncology, colorectal, and reconstructive care. She noted that fluorescence-guided surgery gives surgeons real-time visualization that can easily fit into existing workflows without adding extra equipment. The IC-Flow system can be used across many surgical specialties, making it a practical tool for increasing surgical demand.

These approvals help UltraGreen expand its presence in Southeast Asia and show the company’s long-term commitment to improving precision surgery with high-quality drugs, imaging, and data-driven solutions.